News/ News/ R&D Kiadis shares yo-yo on cell therapy trial for COVID-19 Phil Taylor cell therapy, coronavirus, COVID-19, Kiadis Pharma 0 Comment Shares in Netherlands biotech Kiadis rose sharply on the news that it would start developing a natural killer Share X Kiadis shares yo-yo on cell therapy trial for COVID-19 https://pharmaphorum.com/news/kiadis-shares-yo-yo-on-cell-therapy-trial-for-covid-19/
News/ News/ R&D Kiadis sheds half its staff as lead cell therapy bombs Phil Taylor cell therapy, graft versus host disease, Kiadis Pharma 0 Comment Dutch biotech Kiadis Pharma has abandoned its lead cell therapy and axed half its workforce after a failed Share X Kiadis sheds half its staff as lead cell therapy bombs https://pharmaphorum.com/news/kiadis-sheds-half-its-staff-as-lead-cell-therapy-bombs/
cell therapy, coronavirus, COVID-19, Kiadis Pharma
0 Comment
